Mechanistic new insights of flavonols on neurodegenerative diseases.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021 May

filter terms:

With a large and increasing elderly population, neurodegenerative diseases such as Parkinson's disease (PD), Huntington disease (HD), Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS) and Multiple sclerosis (MS) have become a major and growing health problem. During the past few decades, the elderly population has grown 2.5 % every year. Unfortunately, there are no specific therapeutic remedies available to slow the onset or development of these diseases. An aging brain causes many pathophysiological changes and is the major risk factor for most of the neurodegenerative disorders. Polyphenolic compounds such as flavonols have shown therapeutic potential and can contribute to the treatment of these diseases. In this review, evidence for the beneficial neuroprotective effect of multiple flavonols is discussed and their multifactorial cellular pathways for the progressions of age-associated brain changes are identified. Moreover, the animal models of these diseases support the neuroprotective effect and target the potential of flavonols in the treatment of neurodegenerative diseases. Copyright © 2021. Published by Elsevier Masson SAS.

Citation

Muhammad Shoaib Tahir, Maged Almezgagi, Yu Zhang, Adnan Bashir, Hasnat Mazhar Abdullah, Mohammed Gamah, Xiaozhou Wang, Qinfang Zhu, Xiangqun Shen, Qianqian Ma, Muhammad Ali, Zeeshan Ahmed Solangi, Waseem Sami Malik, Wei Zhang. Mechanistic new insights of flavonols on neurodegenerative diseases. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2021 May;137:111253